|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4708713A
(en)
|
1984-11-16 |
1987-11-24 |
Anisa Medical, Inc. |
Method and system for removing immunosuppressive components from the blood of mammals
|
|
DE3687751T2
(de)
|
1985-09-19 |
1993-05-27 |
Toray Industries |
Kolonne zum entfernen von beta-2-mikroglobulin.
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
EP0319862B1
(de)
|
1987-12-11 |
1994-01-12 |
Akzo Nobel N.V. |
Biocompatible Dialysemembran aus Cellulose mit erhöhter Beta-2-Microglobulinadsorption
|
|
EP0464147B1
(en)
|
1989-03-21 |
2002-06-26 |
THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE |
Matrix metalloproteinase inhibitor peptides
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
US5240614A
(en)
|
1992-01-10 |
1993-08-31 |
Baxter International Inc. |
Process for removing unwanted materials from fluids and for producing biological products
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US6544761B2
(en)
|
1994-12-13 |
2003-04-08 |
Human Genome Sciences, Inc. |
Human tissue inhibitor of metalloproteinase-4
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
GB9607287D0
(en)
|
1996-04-09 |
1996-06-12 |
British Biotech Pharm |
Diagnosis method
|
|
ATE252369T1
(de)
|
1996-08-09 |
2003-11-15 |
Alcon Mfg Ltd |
Konservierungssysteme fur cyclodextrine enthaltende arzneimittel
|
|
US5916202A
(en)
|
1996-08-30 |
1999-06-29 |
Haswell; John N. |
Umbilical cord blood collection
|
|
US6022948A
(en)
*
|
1996-09-17 |
2000-02-08 |
Washington University |
Method of cell surface activation and inhibition
|
|
US5904663A
(en)
|
1997-07-30 |
1999-05-18 |
Braverman; Andrew |
Method of removing beta-2 microglobulin from blood
|
|
US6416487B1
(en)
|
1997-07-30 |
2002-07-09 |
Renal Tech International Llc |
Method of removing beta-2 microglobulin from blood
|
|
US20020159995A1
(en)
|
1997-07-30 |
2002-10-31 |
Renal Tech International |
Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
|
|
US5985263A
(en)
|
1997-12-19 |
1999-11-16 |
Enzon, Inc. |
Substantially pure histidine-linked protein polymer conjugates
|
|
AUPR748501A0
(en)
|
2001-09-04 |
2001-09-27 |
Life Therapeutics Limited |
Renal dialysis
|
|
AUPP790898A0
(en)
|
1998-12-23 |
1999-01-28 |
Life Therapeutics Limited |
Renal dialysis
|
|
CA2702148C
(en)
|
1999-01-06 |
2014-03-04 |
Genenews Inc. |
Method of profiling gene expression in a human subject having an infectious disease
|
|
JP2003506111A
(ja)
|
1999-01-22 |
2003-02-18 |
ザ ダウ ケミカル カンパニー |
血液適合性コーティングを有する表面改質ジビニルベンゼン樹脂
|
|
JP4342027B2
(ja)
*
|
1999-04-01 |
2009-10-14 |
オリエンタル酵母工業株式会社 |
Ｔｉｍｐ修飾体
|
|
UA35656C2
(uk)
|
1999-12-27 |
2001-04-16 |
Олександр Миколайович Макаренко |
Спосіб лікування безперервно прогредієнтних ослабоумлюючих психічних захворювань
|
|
US7582292B2
(en)
|
2000-02-26 |
2009-09-01 |
Artecel, Inc. |
Adipose tissue derived stromal cells for the treatment of neurological disorders
|
|
US6946546B2
(en)
|
2000-03-06 |
2005-09-20 |
Cambridge Antibody Technology Limited |
Human antibodies against eotaxin
|
|
GB0015761D0
(en)
|
2000-06-27 |
2000-08-16 |
Univ Bristol |
Polypeptide
|
|
US6632174B1
(en)
|
2000-07-06 |
2003-10-14 |
Cognifit Ltd (Naiot) |
Method and apparatus for testing and training cognitive ability
|
|
US20020151064A1
(en)
|
2001-02-07 |
2002-10-17 |
Children's Hospital Medical Center |
Regulation of CCR3 expression
|
|
US6475161B2
(en)
|
2001-03-29 |
2002-11-05 |
The Mclean Hospital Corporation |
Methods for diagnosing Alzheimer's disease and other forms of dementia
|
|
US20030139332A1
(en)
|
2001-07-09 |
2003-07-24 |
The Regents Of The University Of California |
Use of matrix metalloproteinase inhibitors to mitigate nerve damage
|
|
US20050071088A1
(en)
|
2001-08-13 |
2005-03-31 |
Landfield Philip W |
Gene expression profile biomarkers and therapeutic targets for brain aging and age-related cognitive impairment
|
|
US6906036B2
(en)
|
2001-08-16 |
2005-06-14 |
Kimberly-Clark Worldwide, Inc. |
Anti-aging and wound healing compounds
|
|
US7608406B2
(en)
|
2001-08-20 |
2009-10-27 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
|
US8105580B2
(en)
|
2001-12-07 |
2012-01-31 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to promote wound healing
|
|
KR100441384B1
(ko)
|
2002-01-08 |
2004-07-21 |
주식회사 안지오랩 |
인간 혈청 알부민-팀프-2 융합 단백질 발현시스템 및재조합 인간 혈청 알부민-팀프-2 융합 단백질
|
|
EP1503786A2
(en)
|
2002-05-10 |
2005-02-09 |
IPF Pharmaceuticals GmbH |
A method of inhibiting the emigration of cells from the intravascular compartment into tissues
|
|
CA2745724C
(en)
|
2002-08-23 |
2015-06-02 |
Bayer Schering Pharma Aktiengesellschaft |
Biomarkers comprising peptide sequence vnhvtlsqpk for diagnosing alzheimer's disease
|
|
EP1394549A1
(en)
|
2002-08-23 |
2004-03-03 |
Bayer HealthCare AG |
Biomarkers for diagnosing Alzheimer's disease
|
|
US20040127445A1
(en)
|
2002-08-28 |
2004-07-01 |
Chondrogene Limited |
Beta-2 microglobulin (B2M) and B2M related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
|
|
US20050244448A1
(en)
*
|
2002-10-14 |
2005-11-03 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Diagnosis and treatment of disorders of collagen and elastin metabolism
|
|
US7060795B2
(en)
*
|
2002-12-19 |
2006-06-13 |
Kimberly-Clark Worldwide, Inc. |
Wound care compositions
|
|
US20040120937A1
(en)
|
2002-12-19 |
2004-06-24 |
Therapy Patent Corporation |
Blood therapy process
|
|
AU2003300379A1
(en)
|
2002-12-27 |
2004-07-29 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods of using collagen and MMPI
|
|
US7785601B2
(en)
|
2002-12-31 |
2010-08-31 |
Sygnis Bioscience Gmbh & Co. Kg |
Methods of treating neurological conditions with hematopoietic growth factors
|
|
WO2004078778A2
(en)
|
2003-03-03 |
2004-09-16 |
Dyax Corp. |
PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
|
|
GB0305133D0
(en)
|
2003-03-06 |
2003-04-09 |
Sinvent As |
Product
|
|
BRPI0408682A
(pt)
|
2003-03-24 |
2006-03-28 |
Actimis Pharmaceuticals Inc |
derivado de benzenossulfonamida, medicamento, uso do derivado de benzenossulfonamida, e, processo para controlar uma doença ou distúrbio inflamatórios ou imuno-reguladores em humanos e animais
|
|
EP1622577A4
(en)
|
2003-04-17 |
2007-09-26 |
Univ Leland Stanford Junior |
PREVENTION OF DEFICIT NEUROGENESIS DISORDERS WITH ANTI-INFLAMMATORY AGENTS
|
|
CA2524325C
(en)
|
2003-06-09 |
2017-08-01 |
John A. Mcintyre |
Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
|
|
US20060094064A1
(en)
|
2003-11-19 |
2006-05-04 |
Sandip Ray |
Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
|
|
US7598049B2
(en)
|
2003-11-19 |
2009-10-06 |
Satoris, Inc. |
Methods for diagnosis of Alzheimer's Disease in blood samples
|
|
US7794704B2
(en)
|
2004-01-23 |
2010-09-14 |
Advanced Cell Technology, Inc. |
Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
|
|
WO2005106492A2
(en)
|
2004-04-30 |
2005-11-10 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3)
|
|
JP4908216B2
(ja)
|
2004-07-23 |
2012-04-04 |
株式会社カネカ |
水不溶性微粒子を除去した吸着材を充填した直接血液灌流用吸着器、および水不溶性微粒子を除去した直接血液灌流用吸着材の取得方法
|
|
US20090209615A1
(en)
|
2004-09-27 |
2009-08-20 |
Stuart Lipton |
Inhibitors of matrix metalloproteinases to treat neurological disorders
|
|
WO2006066089A1
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Humanized amyloid beta antibodies for use in improving cognition
|
|
EP2385066A1
(en)
|
2005-03-18 |
2011-11-09 |
Oregon Health & Science University |
Recombinant MHC Molecules Useful for Manipulation of Antigen-Specific T Cells
|
|
DK1929297T3
(da)
|
2005-09-29 |
2013-03-04 |
Caprion Proteomics Usa Llc |
Biomarkører for dissemineret sklerose og fremgangsmåder til anvendelse heraf
|
|
WO2007059135A2
(en)
|
2005-11-10 |
2007-05-24 |
Satoris, Inc. |
Methods of treating alzheimer's disease
|
|
US20080125354A1
(en)
|
2005-11-21 |
2008-05-29 |
Florida Atlantic University |
Selective inhibition of matrix metalloproteinases
|
|
US7908090B2
(en)
|
2005-11-30 |
2011-03-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Signatures for human aging
|
|
US20090227673A1
(en)
|
2006-01-13 |
2009-09-10 |
Bao Ting Zhu |
Method and Composition for the Treatment of Parkinson's Disease
|
|
US10344095B2
(en)
|
2006-02-16 |
2019-07-09 |
University Of Kentucky Research Foundation |
CCR3 inhibition for ocular angiogenesis and macular degeneration
|
|
US8828977B2
(en)
|
2006-02-16 |
2014-09-09 |
Discogen, Llc |
Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor
|
|
JP2009149524A
(ja)
|
2006-03-16 |
2009-07-09 |
Kyushu Univ |
アルツハイマー病の予防・治療剤
|
|
WO2007123976A2
(en)
|
2006-04-18 |
2007-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Antibody profiling for determination of patient responsiveness
|
|
EP2302395B1
(en)
|
2006-06-07 |
2015-04-15 |
Health Diagnostic Laboratory, Inc. |
Markers associated with arteriovascular events and methods of use thereof
|
|
US7851172B2
(en)
|
2006-07-25 |
2010-12-14 |
University Of Kentucky Research Foundation |
Biomarkers of mild cognitive impairment and alzheimer's disease
|
|
US7592009B2
(en)
*
|
2006-10-10 |
2009-09-22 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Polypeptide ligands for targeting cartilage and methods of use thereof
|
|
US8211310B2
(en)
|
2006-11-20 |
2012-07-03 |
Cytosorbents, Inc. |
Size-selective polymer system
|
|
WO2008106076A2
(en)
*
|
2007-02-27 |
2008-09-04 |
Merck & Co., Inc. |
Methods for monitoring disease progression of alzheimer's disease using csf markers from longitudinal samples
|
|
EP2139497B1
(en)
|
2007-04-13 |
2013-11-06 |
Stemnion, INC. |
Methods for treating nervous system injury and disease
|
|
GB0710522D0
(en)
|
2007-06-01 |
2007-07-11 |
Royal Veterinary College The |
Drug delivery system comprising matrix metalloproteinase inhibitors
|
|
BRPI0815551A2
(pt)
|
2007-08-15 |
2015-02-18 |
Univ South Florida |
Tratamento através de hucbc de doença beta-amiloide
|
|
US8097645B2
(en)
|
2007-10-12 |
2012-01-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds for activating TGF-β signaling
|
|
US20090227018A1
(en)
|
2007-10-25 |
2009-09-10 |
Revalesio Corporation |
Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
|
|
US20100310609A1
(en)
|
2007-10-25 |
2010-12-09 |
Revalesio Corporation |
Compositions and methods for treatment of neurodegenerative diseases
|
|
US20100015235A1
(en)
|
2008-04-28 |
2010-01-21 |
Revalesio Corporation |
Compositions and methods for treating multiple sclerosis
|
|
CN101888863B
(zh)
|
2007-12-06 |
2012-11-28 |
旭化成医疗株式会社 |
血液处理用多孔中空纤维膜
|
|
JP5539965B2
(ja)
*
|
2008-04-28 |
2014-07-02 |
レバレジオ コーポレイション |
多発性硬化症を治療するための組成物および方法
|
|
US20110142848A1
(en)
|
2008-08-07 |
2011-06-16 |
Chung Leland W K |
Anti-beta-2-microglobulin agents and the use thereof
|
|
US8802627B2
(en)
|
2008-10-09 |
2014-08-12 |
Oriental Yeast Co., Ltd. |
Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-B precursor protein and tissue inhibitor of metalloproteinase-2
|
|
US20100124756A1
(en)
|
2008-10-10 |
2010-05-20 |
Sandip Ray |
Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids
|
|
US20110117100A1
(en)
|
2008-11-03 |
2011-05-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for diagnosis, stratification and treatment of amyloidogenic diseases
|
|
US8778616B2
(en)
|
2009-05-26 |
2014-07-15 |
University Of Kentucky Research Foundation |
Method of using CCR3 binding agents to detect choroidal neovascularization
|
|
US20160208011A1
(en)
|
2010-01-28 |
2016-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
|
|
US20130040844A1
(en)
|
2010-01-28 |
2013-02-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Biomarkers of aging for detection and treatment of disorders
|
|
US10626399B2
(en)
|
2010-01-28 |
2020-04-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
|
|
US20110202284A1
(en)
|
2010-02-10 |
2011-08-18 |
Mcreynolds Cristopher |
Novel groups of biomarkers for diagnosing alzheimer's disease
|
|
RU2428997C1
(ru)
|
2010-03-01 |
2011-09-20 |
Федеральное государственное образовательное учреждение высшего профессионального образования Волгоградская государственная сельскохозяйственная академия |
Способ получения лечебных препаратов из пуповины плода
|
|
AR080698A1
(es)
|
2010-04-01 |
2012-05-02 |
Imclone Llc |
Anticuerpo o fragmento del mismo que especificamente enlaza la variante de csf -1r humano, composicion farmaceutica que lo comprende, su uso para la manufactura de un medicamento util para el tratamiento de cancer y metodo para determinar si un sujeto es candidato para tratamiento de cancer basado e
|
|
TR201900368T4
(tr)
|
2010-05-04 |
2019-02-21 |
Five Prime Therapeutics Inc |
Csf1r'ye bağlanan antikorlar.
|
|
US9161968B2
(en)
|
2011-04-08 |
2015-10-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
|
|
CN103827671B
(zh)
*
|
2011-05-03 |
2017-05-03 |
联邦科学与工业研究组织 |
用于检测神经疾病的方法
|
|
US9782457B2
(en)
|
2011-10-07 |
2017-10-10 |
Tissue Repair Company |
Flowable formulations for tissue repair and regeneration
|
|
RU2470677C1
(ru)
|
2011-10-19 |
2012-12-27 |
Надежда Михайловна Цулая |
Способ стимуляции репаративных и трофических процессов в коже
|
|
WO2013063086A1
(en)
|
2011-10-24 |
2013-05-02 |
Intellect Neurosciences, Inc. |
Compositions and methods for treatment of proteinopathies
|
|
CN104884611A
(zh)
|
2012-02-13 |
2015-09-02 |
孔五一 |
Nprcp、pfdnc和它们的应用
|
|
MX2014011186A
(es)
|
2012-03-20 |
2015-03-06 |
Einstein Coll Med |
Metodo para mejorar la eficiencia de las transfusiones de sangre.
|
|
US20130302322A1
(en)
|
2012-05-11 |
2013-11-14 |
Five Prime Therapeutics, Inc. |
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
|
|
US9512052B2
(en)
|
2012-10-29 |
2016-12-06 |
China Petroleum & Chemical Corporation |
Adsorption desulfurization process for hydrocarbons and a reaction apparatus therefor
|
|
EP2781523A1
(en)
|
2013-03-18 |
2014-09-24 |
Miltenyi Biotec GmbH |
Lipophilic oligonucleotide analogs
|
|
US11885816B2
(en)
|
2013-11-26 |
2024-01-30 |
University Of North Texas Health Science Center At Forth Worth |
Personalized medicine approach for treating cognitive loss
|
|
CN106163530A
(zh)
|
2013-12-09 |
2016-11-23 |
小利兰·斯坦福大学托管委员会 |
用于治疗衰老相关病症的方法和组合物
|
|
US10905779B2
(en)
|
2013-12-09 |
2021-02-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening human blood products comprising plasma using immunocompromised rodent models
|
|
CA2945953A1
(en)
|
2014-04-16 |
2015-10-22 |
Blood Systems Research Institute |
Method and composition for conferring neuroprotection
|
|
CA2984645C
(en)
|
2015-05-18 |
2023-01-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for treating aging-associated impairments
|
|
US10617744B2
(en)
|
2015-06-15 |
2020-04-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for treating aging-associated conditions
|